Werner, Rudolf A.
Bundschuh, Ralph A.
Bundschuh, Lena
Lapa, Constantin
Yin, Yafu
Javadi, Mehrbod S.
Buck, Andreas K.
Higuchi, Takahiro
Pienta, Kenneth J.
Pomper, Martin G.
Lodge, Martin A.
Gorin, Michael A.
Rowe, Steven P.
Funding for this research was provided by:
Progenics Pharmaceuticals (N/A)
Foundation for the National Institutes of Health (CA134675, CA183031, CA184228, EB024495)
Prostate Cancer Foundation (N/A)
European Union (701983)
Article History
First Online: 28 May 2019
Compliance with Ethical Standards
:
: Martin G. Pomper is a coinventor on a patent covering [<sup>18</sup>F]DCFPyL and is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. He has also received research funding from Progenics Pharmaceuticals, the licensee of [<sup>18</sup>F]DCFPyL. Michael A. Gorin has served as a consultant to, and has received research funding from, Progenics Pharmaceuticals. Kenneth J. Pienta has received research funding from Progenics Pharmaceuticals. Steven P. Rowe has received research funding from Progenics Pharmaceuticals.